Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_361c6223f33de77431dc880348294a7c |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-207 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7076 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7076 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-16 |
filingDate |
2016-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_434d98a1ceff3eab095884b141893a7e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_575ae645b209afd6ef29f8d5166d1981 |
publicationDate |
2021-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EA-037098-B1 |
titleOfInvention |
-D-2'-DESOXY-2 '- FLUORINE-2' - C-SUBSTITUTED-2-MODIFIED-N6-SUBSTITUTED PURINE NUCLEOTIDES FOR THE TREATMENT OF HCV-INDUCED DISEASES |
abstract |
A compound of structure or a pharmaceutically acceptable salt or composition thereof for the treatment of hepatitis C virus (HCV) in humans is disclosed. Also disclosed is the use of said compound in the treatment of HCV and for the manufacture of a medicament for the treatment of HCV in humans. |
priorityDate |
2015-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |